Event-Driven Stocks

Dimension Therapeutics, Inc.

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

Signs3 good3 warning1 severedetails ↓

Financials

SEC XBRL · annual
 FY16FY15FY14
Revenue$2.2M$1.6M$2.8M
Operating income−$49.0M−$35.0M−$13.0M
Net income−$49.0M−$35.1M−$13.0M
Total assets$93.9M$133.3M$22.1M
Total liabilities$33.9M$27.7M$26.7M
Equity$59.9M$105.6M−$14.2M
EPS (diluted)
Shares out.25.0M25.0M4.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2016
Operating margin
−2223.5%
Net margin
−2221.3%
Return on equity
−81.7%
Return on assets
−52.2%
Return on capital (ROCE)
−67.0%
Liabilities / assets
36.1%
Debt / equity
0.57×
Book value / share
$2.40
Revenue growth (YoY)
38.4%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2016
Altman Z″ (distress)
-0.62distress
Accruals / assets
1.4%clean
Piotroski F-Score
2/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
55
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

1 severe3 warning3 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Insider transactions

SEC Form 4 · most recent
0 acquisitions2 disposalsnet 4.1M shares · last 2
InsiderDateTypeSharesPrice
Fmr LlcNov 7, 2017U3.8M$6.00
Wadsworth Samuel C.Officer — Chief Scientific OfficerNov 7, 2017D278,035

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.